Global Type 1 Diabetes Market 2014-2018.pdf

NEW YORK, Aug. 18, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Type 1 Diabetes Market 2014-2018.pdf

http://www.reportlinker.com/p02170312/Global-Type-1-Diabetes-Market-2014-2018pdf.html

About Type 1 DiabetesType 1 diabetes is an autoimmune disorder characterized by high blood glucose levels. In this condition, the immune system is activated against self-insulin producing cells. This, in turn, hampers the body's ability to produce insulin and disrupts blood glucose homeostasis. Type 1 diabetes T1D differs from the more common form of diabetes mellitus, Type 2 diabetes, as people with Type 2 diabetes do produce insulin. T1D accounts for only 5-15 percent of the total diabetic cases and is usually reported in children and adolescents. T1D was formerly known as juvenile diabetes. T1D management relies on providing symptomatic relief and improving quality of life.TechNavio's analysts forecast the Global Type 1 Diabetes Market will grow at a CAGR of 6.9 percent over the period 2013-2018.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Type 1 Diabetes Market for the period 2014-2018. To calculate the market size, the report considers revenue generated from the sales of various type 1 diabetes management drugs, which includes insulin-based replacement products and amylin analogues.

TechNavio's report, the Global Type 1 Diabetes Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Type 1 Diabetes market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

• Americas

• EMEA

• APAC

Key Vendors

• Astrazeneca plc

• Eli Lilly and Co.

• Novo Nordisk A/S

• Sanofi-Aventis US LLC

Other Prominent Vendors

• Biodel Inc.• Diamyd Medical AB• DiaVacs Inc.• Generex Biotechnology Corp.• Lexicon Pharmaceuticals Inc.• Macrogenics Inc.• MannKind Corp.• Osiris Therapeutics Inc.• Tolerion Inc.• XOMA Corp.

Key Market Driver

• Increasing Global Type 1 Diabetic Population.

• For a full, detailed list, view our report.

Key Market Challenge

• Side Effects of Current Therapies.

• For a full, detailed list, view our report.

Key Market Trend

• Focus on Emerging Markets.

• For a full, detailed list, view our report.

Key Questions Answered in this Report

• What will the market size be in 2018 and what will the growth rate be?

• What are the key market trends?

• What is driving this market?

• What are the challenges to market growth?

• Who are the key vendors in this market space?

• What are the market opportunities and threats faced by the key vendors?

• What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

•

01. Executive Summary02. List of Abbreviations03. Scope of the Report03.1 Market Overview03.2 Product Offerings04. Market Research Methodology04.1 Market Research Process04.2 Research Methodology05. Introduction06. Market Landscape06.1 Market Overview06.2 Market Size and Forecast06.3 Five Forces Analysis07. Global Market Share by Products08. Product Portfolio09. Clinical Pipeline Portpolio10. Geographical Segmentation11. Buying Criteria12. Market Growth Drivers13. Drivers and their Impact14. Market Challenges15. Impact of Drivers and Challenges16. Market Trends17. Trends and their Impact18. Vendor Landscape18.1 Competitive Scenario18.1.1 Key News18.1.2 Mergers and Acquisitions18.2 Market Share Analysis 201318.3 Future Vendors Expected to Tap the Market

List of Exhibits

Exhibit 1: Market Research Methodology

Exhibit 2: Global Type 1 Diabetes Drugs Market 2013-2018 (US$ million)

Exhibit 3: Global Market Share of Diabetes Drugs 2013 (US$ million)

Exhibit 4: Global Type 1 Diabetes Market by Geographical Segmentation 2013

Exhibit 5: Incidence and Prevalence of Type1 Diabetes in Children (0-14 Years) 2013 (in thousands)

Exhibit 6: Market Share of Vendors in Global Type 1 Diabetes Market (in Percent)

Exhibit 7: Revenue Share of Novo Nordisk's Insulin Products (in Percent)

Exhibit 8: Novo Nordisk's Insulin Products Revenue Segmentation by Geography (in Percentage)

Exhibit 9: Geography Wise Revenue of Novo Nordisk's Insulin Products (US$ million)

Exhibit 10: Eli Lilly's Insulin Products Revenue Segmentation by Geography (in Percentage)

Exhibit 11: Geography Wise Revenue of Eli Lilly's Insulin Products (US$ million)

Exhibit 12: Sanofi's Insulin Products Revenue Segmentation by Geography (in Percentage)

To order this report: Global Type 1 Diabetes Market 2014-2018.pdf http://www.reportlinker.com/p02170312/Global-Type-1-Diabetes-Market-2014-2018pdf.html

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker